CROI 2020

 

Accepted Abstracts & Presentations> CROI 2020

2020 Conference on Retroviruses and Opportunistic Infections (CROI)


8-11 March 2020

See more on the CROI website.

 

IMPAACT study results from 14 abstracts were presented virtually at the 2020 Conference on Retroviruses and Opportunistic Infections (CROI). Presentations will be published as permissions for posting are received. The following were presented:

  • Three abstracts as oral presentations (IMPAACT 2010/VESTED, IMPAACT 2003/A5300/PHOENIx, and IMPAACT 2001)
  • Three abstracts as posters with themed discussions (IMPAACT 2007, P1106, and A5316)
  • Eight abstracts as poster presentations (IMPAACT 2009, P1115, P1112, P1101, P1078, PROMISE, P1041, and laboratory analyses)


>> Download the IMPAACT at CROI 2020 Full Listing <<

 

Protocol
Title
Authors
Presentation Type
Monday 9 March


IMPAACT 2009

 

TFV-DP in DBS for Pregnant/ Postpartum Adolescent and Young Women on PrEP in Africa


Anderson P, Stranix-Chibanda L, Huang S, Hosek S, Kacanek D, Nematadzira T, Taulo F, Korutaro V, Nakabiito C, Masenya M, Lypen K, Chakhtoura N, Spiegel H, Chi BH, on behalf of the IMPAACT 2009 team


Poster Presentation
2:30 PM – 4:00 PM


P1078


Adjusted Analysis of Effect of IPT on Adverse Pregnancy Outcomes in Women with HIV


Theron G, Chakhtoura N, Montepiedra G, Aaron G, Jean-Philippe P, Weinberg A, McCarthy K, Nematadzira T, Masheto G, Chipato T, Onyango-Makumbi C, Gupta A, the IMPAACT P1078 Team


Poster Presentation
2:30 PM – 4:00 PM


Lab


Trehalose Inhibits HIV Infection in CD4+ Lymphocytes and Macrophages by Two Distinct Mechanisms

 

Rawat P, Hon S, Teodorof-Diedrich C, Spector SA


Poster Presentation
2:30 PM – 4:00 PM

Tuesday 10 March


IMPAACT 2007


Maraviroc Safety & Pharmacokinetics in HIV-exposed Neonates


Rosebush J, Best B, Chadwick E, Moye J, Smith E, Butler K, Bradford S, Whitson K, Mathiba SR, Hanley S, Aziz M, Hayward K, Mirochnick M, Samson P, for the IMPAACT 2007 Study Team


Themed Discussion
1:30 PM – 2:30 PM

Poster Presentation
2:30 PM – 4:00 PM


P1106

 

Abacavir Safety and Pharmacokinetics in Normal and Low Birth Weight Infants with HIV


Cressey TR, Bekker A, Cababasay M, Wang J, Moye J, Violari A, Cotton M, Wiesner L, Rabie H, Mirochnick M, Capparelli E, IMPAACT P1106 team


Themed Discussion
1:30 PM – 2:30 PM

Poster Presentation
2:30 PM – 4:00 PM


A5316

 

A Combined Estrogen/Progestin Vaginal Ring Improves Vaginal Microbial Communities


Tobin NH, Brooker S, Li F, Cramer YS, Rosenkranz S, Aldrovandi GM, Coombs R, Cohn S, Zorrilla C, Moran L, Berzins B, Scarsi KK, Godfrey C, for the ACTG 5316 Team


Poster Presentation
(10 March)
2:30 PM – 4:00 PM

Themed Discussion
(11 March)
1:30 PM – 2:30 PM


DR 808 (P1112, P1115, PACTG230, PACTG326)

 

Cost-effectiveness of Broadly Neutralizing Antibodies for Infant HIV Prophylaxis


Dugdale CM, Permar SR, Stranix-Chibanda L, Walensky RP, Fouda GG, Myer L, Cunningham CK, Weinstein MC, Leroy V, McFarland EJ, Freedberg KA, and Ciaranello AL


Poster Presentation
2:30 PM – 4:00 PM


P1101

 

Pharmacokinetics of Raltegravir in HIV/TB Co-Treated Infants and Young Children


Krogstad P, Samson P, Acosta E, Moye J, Townley E, Bradford S, Brown E, Graham B, Hovind L, Teppler H, Mathiba SR, Masebole M, Cotton M, Winckler J, Meyers T


Poster Presentation
2:30 PM – 4:00 PM

Wednesday 11 March


IMPAACT 2010

 

Safety and Efficacy of DTG vs EFV and TDF vs TAF in Pregnancy: IMPAACT 2010 Trial


Chinula L, Brummel S, Ziemba L, Stranix-Chibanda L, Coletti A, Krotje C, Jean-Philippe P, Fairlie L, Vhembo T, Wabwire D, Hoffman R, Sax P, Stringer J, Currier J, Lockman S


Oral Presentation
10:00 AM – 12:00 PM


IMPAACT 2001

 

Rifapentine Pharmacokinetics and Safety in Pregnant Women with and without HIV on 3HP

 

Mathad JS, Savic R, Britto P, Wiesner L, Townley E, Chakhtoura N, Bradford S, Patil S, Vhembo T, Lespinasse D, Langat D, Werarak P, Kamthunzi P, Gupta A, Dooley KE


Oral Presentation
10:00 AM – 12:00 PM


A5300/IMPAACT 2003

 

Predictors of Tuberculosis Infection in MDR-TB Household Contacts ≥15 years old


Kim S, Gupta A, Wu X, Hughes M, Dawson R, Mave V, Kumarasamy N, Smith B, Rustomgee R, Shah NS, Hesseling A, Swindells S, Churchyard G, ACTG/IMPAACT A5300/I2003 PHOENIx Feasibility Study Team


Oral Presentation
10:00 AM – 12:00 PM


Lab

 

HIV Exposure and Human Milk Oligosaccharides Modulate the Infant Gut Microbiota

 

Brooker SL, Tobin NH, Li F, Kuhn L, Aldrovandi GM


Poster Presentation
2:30 PM – 4:00 PM


NWCS 619 (PROMISE)

 

Metabolites, Preterm Labor and Antiretroviral Therapy


Tobin NH, Murphy A, Li F, Brummel S, Fowler MG, McIntyre J, Currier JS, Chipato T, Flynn P, Koos B, Aldrovandi GM, and the PROMISE team


Poster Presentation
2:30 PM – 4:00 PM


P1041


Evaluation of a Blood-based Antigen Test for Tuberculosis in Infants


Mao L, LaCourse SM, Kim S, Liu C, Jiao W, Lyon CJ, Nachman S, Mitchell CD, Hu Y


Poster Presentation
2:30 PM – 4:00 PM

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.